Be sure to check our sister interview main ratings news website

STBX

SkinBiotherapeutics Plc

INTERVIEW: SkinBioTherapeutics PLC Increased Attention

4th October 2017

SkinBioTherapeutics PLC (LON:SBTX) CEO Dr. Catherine O’Neill talks to DirectorsTalk about passing 3rd party cellular toxicity tests. Catherine explains what was involved and what this means for the company, key

Interviews

The International Stock Exchange strong first half of 2023 (VIDEO)
The International Stock Exchange strong first half of 2023...
The International Stock Exchange is...
Cizzle Biotechnology programme with US firm Bio-Techne takes major step forward (VIDEO)
Cizzle Biotechnology programme with US firm Bio-Techne takes major...
Cizzle Biotechnology plc (LON:CIZ) Executive Chairman...
Nuformix excited as it moves focus to NXP002 and NXP004 programmes
Nuformix excited as it moves focus to NXP002 and...
Nuformix plc (LON:NFX) Executive Director Dan...
Argentex Group growth strategy clearly paying off (VIDEO)
Argentex Group growth strategy clearly paying off (VIDEO)
Argentex Group (LON:AGFX) Chief Executive Officer...
The Diverse Income Trust Gervais Williams upbeat for the UK to outperform (VIDEO)
The Diverse Income Trust Gervais Williams upbeat for the...
The Diverse Income Trust (LON:DIVI) Head...

Funds

Where are the bright spots in emerging markets?
Where are the bright spots in emerging markets?
How customisation and liquidity are shaping the future of private credit fund structuring
How customisation and liquidity are shaping the future of private credit fund structuring
Investors cautious ahead of Central Bank meetings
Investors cautious ahead of Central Bank meetings
BlackRock Income and Growth Investment Trust performance in-line with FTSE All-Share
BlackRock Income and Growth Investment Trust performance in-line with FTSE All-Share
Why UK commercial property might be more resilient than you think
Why UK commercial property might be more resilient than you think
Volta Finance Limited declares its quarterly interim dividend
Volta Finance Limited declares its quarterly interim dividend

Presentations

Poolbeg Pharma Investment Case
Poolbeg Pharma Investment Case
Poolbeg Pharma (LON:POLB / OTCQB:POLBF) Investment Case...
Accrol Group Holdings Investor Presentation 2023
Accrol Group Holdings Investor Presentation 2023
Accrol Group Holdings (LON:ACRL) CEO Gareth...
Active Energy Group Plc (LON:AEG) CEO Michael Rowan talks us through the 2023 Business Update
Active Energy Group Plc (LON:AEG) CEO Michael Rowan talks us...
https://vimeo.com/789986536 Active Energy (LON:AEG, OTCQB:ATGVF),...
TEAM Plc’s Mark Clubb reviews 2022 and sets out the Company plans for 2023
TEAM Plc’s Mark Clubb reviews 2022 and sets out...
TEAM Plc (LON:TEAM) financial results for...
Active Energy Group overview with Michael Rowan CEO
Active Energy Group overview with Michael Rowan CEO
Active Energy Group Plc (LON:AEG) CEO...

Broker Talk

Tissue Regenix results demonstrate success of TRX’s “4S” strategy
Tissue Regenix results demonstrate success of TRX’s “4S” strategy
The International Stock Exchange to continue to expand its customer base
The International Stock Exchange to continue to expand its customer base
Real Estate Credit Investments: Why CRE equity worries should not apply to RECI
Real Estate Credit Investments: Why CRE equity worries should not apply to RECI
H&T Group: Delivering the pawnbroking growth opportunity
H&T Group: Delivering the pawnbroking growth opportunity
Shield Therapeutics share price hitting highest level since November 2022
Shield Therapeutics share price hitting highest level since November 2022
ICG Enterprise Trust: Investor Day – defensive growth in practice
ICG Enterprise Trust: Investor Day – defensive growth in practice

© 2023 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.